Fierce Biotech – Enyo Pharma raises $47M to bring hepatitis B, NASH drug to phase 2

https://www.fiercebiotech.com/biotech/enyo-raises-47m-to-bring-hep-b-nash-drug-to-phase-2

Read next in 'Media coverage'